Neko Health Secures $700M in Series C Funding

Neko Health, a body-scanning and health assessment startup founded by Spotify's Daniel Ek and Hjalmar Nilsonne, has raised a $700 million Series C. The round was led by Lightspeed Venture Partners and O.G. Venture Partners, following the company's $260 million Series B raised in January 2025.

Neko Health has developed proprietary body-scanning technology, which it couples with bloodwork, to assess a person's health. The scan also includes body composition information for gym enthusiasts. It can integrate the assessment with Apple Health data, providing medical clinicians with real-world data for its evaluations.

Neko Health operates in the U.K. and Sweden, with plans to open its first U.S. location in New York.

Over 100,000 people have undergone scans, and more than 350,000 individuals have registered for the waitlist or scheduled appointments. Calm founder Alex Tew, who had a Neko Health scan, credits the company with detecting a malignant mole on his back, which he subsequently had removed. "I'm grateful to Neko for helping me discover this – I'm not sure how I would have otherwise." Other investors in Neko Health's latest round include Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum, and BDT & MSD.

Why this matters: Neko Health's substantial funding round highlights the growing interest in preventive healthcare and advanced diagnostic technologies. The company's integration of body-scanning and bloodwork assessments, combined with Apple Health data, positions it at the forefront of personalized medicine. As Neko Health expands into the U.S.

market, it may challenge traditional healthcare providers to adopt similar innovative approaches. For developers and businesses, this investment signals opportunities in health tech and AI-driven diagnostics. However, questions remain about data privacy, the accessibility of such services, and how they will be covered by insurance providers.

The success of Neko Health and similar startups will likely influence the broader healthcare industry, pushing for more proactive and personalized care solutions.